ABOUT IPS

IPS-Integrated Project Services is a global provider of technical consulting, architecture, engineering, project controls, construction management, and CGMP compliance services for technically complex pharmaceutical development and manufacturing facilities worldwide.

FEATURED SERVICES

Our team of design experts collaborate with our clients to envision a facility's strategic future - evaluating its current capacity versus the long-term needs. We interview stakeholders and users, collect, document, and analyze resourcing, building, and process data to build a road map to guide decision making.

Our highly specialized team of process architects - one of the deepest and strongest in the world - work with our clients to design facilities and processes that manufacture the most technically advanced, scientific products in the pharmaceutical and life sciences industries.

IPS is the recognized leader in the design of technically complex product development and manufacturing facilities around the world. Our cross-functional approach to design delivers value throughout the entire design process; from feasibility studies through detailed design and construction assistance.

Our cross functional teams of technical and subject matter experts, many of whom come from industry, have successfully collaborated with clients around the world to produce facility and site master plans identify the gaps between business needs and facility and site assets. Our proven five-step process of: aligning, collecting, analyzing, developing, and recommending achieves an outcome focused on the goals and objectives.

The construction management team delivers comprehensive turnkey construction management services spanning the entire execution process - from pre-design consulting, constructability analysis, through occupancy - across geographic regions, industry sectors, and facility types. We utilize lean construction and project delivery tools and techniques including offsite and modular construction to reduce waste and build value throughout each phase of project delivery, without compromising safety.

Our technical automation and instrumentation experts continuously evaluate and implement automation technologies and systems that move us toward Industry 4.0. Our experts deliver solutions in automation strategies and evaluation, SCADA and control system upgrades, building automation, and technology obsolescence management plans.

Our industry-leading compliance subject matter experts combine their technical and operational expertise in the areas of design, construction, commissioning, qualification, and validation to produce fully operational and compliant commercial operations.

Using our integrated EPCMV process allows us to deliver exceptional manufacturing facilities to the clients we serve. We understand the complex nature of the systems and structures in the facilities we produce. From bioreactors to powder transfer systems, cosmetics to medical devices, we are at the forefront of the latest advances in the industry. Our approach takes a holistic view of each project. We provide the latest, proven concepts to deliver exceptional results for the clients we serve.

Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your specialty lab needs. 

At the forefront of the industry, our experts continuously acquire knowledge on the latest technologies, equipment, and methodologies to prepare goods for distribution. The IPS packaging teams tailor solutions to the unique challenges and desires of our clients. Partnerships with our clients are key to a successful project that produces a result specific to the project goals and objectives. Working together, we define a balance between efficiency, flexibility, quality, and cost that is unique to each facility and installation all the while maintaining focus on regulatory requirements.

IPS and GCON have partnered to create iCON, a turnkey modular facility platform solution for the biomanufacturing industry. The collaboration provides the most flexible and rapidly deployable facility platform, meeting the modular and mobile demands of the industry. The iCONteam's broad range of technical capabilities and services along with prefabricated cleanroom PODs provides a true turnkey solution to biopharmaceutical manufacturers and CMOs with needs for production agility and capacity flexing.

We are internationally recognized as experts in advanced aseptic processing and risk-based isolation and barrier technologies. Our experience, awareness and understanding of industry trends places importance on time-to-market, plant flexibility and cost control to avoid costly project delays and minimize risk.

Whether the products are new or existing, our Drug Development and Technology Transfer services offer solutions that consistently maintain quality and compliance to effectively accelerate scale-up through market launch. Our experts provide ideas that speed pharmaceutical and biotech products to market.

Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your laboratory needs.

Knowing the technology, industry trends, regulatory environment and manufacturing processes enables our process/bioprocess engineers to identify opportunities to streamline production and maximize efficiency.

With technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.

With biomanufacturing technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.

We provide the knowledge, flexibility and technical expertise through our risk-based approach designed to reduce risk, lower costs, improve efficiency and productivity and comply with mandates and requirements. We minimize the impact of operations through energy management programs and our unique solutions to modernize facilities and reduce the environmental footprint.

For over twenty-five years, IPS has delivered fully integrated Engineering, Construction, Project Controls, Commissioning and Qualification services to the pharmaceutical industry. Our team imparts Knowledge, Skill and Passion to develop solutions that improve efficiency, productivity, financial performance and minimize overall cost and risk.

CONTACT INFORMATION

IPS-Integrated Project Services

721 Arbor Way, Suite 100

Blue Bell, PA 19422

UNITED STATES

Phone: 610.828.4090

Contact: Sales

FEATURED ARTICLES

  • IPS Recognized For Its Contribution To United Therapeutics Facility In Maryland

    Learn about United Therapeutics winning the Social Impact category for the 2020 ISPE Facility of the Year Award:

  • IPS Announces Commitment To Employees During COVID-19 Crisis

    IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces an employee retention plan that secures jobs for their entire global staff, nearly 1,400 employees.

  • IPS Announces New Office In Cherry Hill, NJ For Pharma, Cell / Gene / Bio Clients

    IPS-Integrated Project Services, LLC, a leading provider of Engineering, Procurement, Construction Management and Commissioning, Qualification, and Validation (EPCM/CQV) services, announces the continued expansion in the Americas region with the opening of a new office located in Cherry Hill, New Jersey.

  • IPS Launches End-To-End Integrated Operational Readiness Compliance Solution For Cell And Gene Therapy Facilities

    IPS-Integrated Project Services, LLC, a leading provider of consulting, architecture, engineering, construction management, and CGMP compliance services, announces the launch of CarTon, an end-to-end integrated operational readiness compliance solution for cell and gene therapy facilities.

  • What Cell and Gene Companies Need To Know About Leasing Space

    One of the most significant moves for a growing biotech or pharmaceutical company — sometimes considered as a graduation step — is the acquisition of property to conduct clinical trials and manufacture commercial products. In the first installment of this two-part series, we will explore what considerations companies need to make before they decide what type of property to pursue.

  • IPS Establishes Germantown, Maryland Facility To Serve Biopharma Industry Needs

    IPS-Integrated Project Services, LLC, a leading provider of Engineering, Procurement, Construction Management and Validation (EPCMV) services, announces the continued expansion in the Americas with the opening of a new office located in Germantown, Maryland.

  • Overcoming The Unique Filling Challenges Of Autologous Therapies

    Autologous (patient-derived) therapies represent unique challenges to processing. One-patient, single-batch is a radical change from the scale our industry is accustomed to. At this level the filling is more analogous to limited Phase 1 clinical trial materials or even preclinical applications. The logistics and required compliance of manufacturing these personalized therapies is drastically different and presents a combinatorial explosive problem. One aspect of this process where traditional methods fall apart is filling of these therapies.

  • IPS Provides Engineering Solutions To BWXT For The Development And Commercialization Of Diagnostic Medical Isotopes

    IPS-Integrated Project Services, ULC, a leading provider of Engineering, Procurement, Construction Administration and Validation (EPCAV) services, was selected by BWXT ITG Canada, Inc. to provide Basis of Design and Detailed Design for BWX Technologies, Inc.'s (BWXT) isotope project, specifically the expansion of their medical isotope and radiopharmaceutical facility in Ottawa, Ontario, Canada.

  • IPS To Design New Nexus Pharmaceuticals Manufacturing Facility In Wisconsin

    Nexus Pharmaceuticals Inc., a woman-owned, privately held, US-based healthcare company, announced recently an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading sterile injectable manufacturing facility.

  • Lupin Project Wins ENR Global Best Project Award Of Merit: Manufacturing

    ENR's Global Best Projects identifies and honors the project teams behind outstanding design and construction efforts of the past year. They received a record number of entries produces a diverse set of projects located in 20 countries that focused on safety performance, innovations, challenges, and design and construction quality - with a special emphasis on the diversity of global project teams and their collaboration.

  • IPS Showcases INNOPHEX And Pharma 4.0 At Their Annual Technologies Tours At INTERPHEX

    IPS-Integrated Project Services, LLC (IPS), a leading provider of Engineering, Procurement, Construction Management and Validation (EPCMV) services, announces the ninth annual IPS Technologies Tours at INTERPHEX with Tours focused on the hottest trends in the industry, including Pharma 4.0 concepts, cell processing, and gene therapy.

     

  • Dos & Don’ts Of Bioprocess Facility Construction

    Expansions and renovations to existing biological facilities, and construction of new facilities, provide a unique opportunity to rethink basic design strategies and use new technologies to build a better facility that will improve compliance. This article is the sixth in a six-part series on how single-use systems (SUS) are changing the modern biotechnology facility design and construction paradigm.

  • Cell Therapy: Process Design Considerations To Support Commercialization

    Cell therapies have the potential to revolutionize the biopharmaceutical world, but today’s processes, logistics, and delivery make for a challenging entry into the sector’s growth curve. As the industry evolves, we have to answer (at least) three important questions when bringing these exciting new therapies to market.

  • Designing The Cell Therapy Facility Of The Future

    In 1931, Swiss doctor Paul Niehans injected a preparation of live cells from a parathyroid gland into a dying patient. The patient subsequently recovered, and Dr. Niehans had a eureka moment — that injections of living cells can have tremendous therapeutic value.

  • A Checklist For Engineering Due Diligence In Pharma M&As

    Pharmaceutical plants cannot be treated like real estate. Instead, they require a detailed assessment of where they are in “operational compliance and production readiness.”

  • Biocontainment: An Introduction To Control Levels & Practical Design Concepts

    In part 1 of our article on biocontainment, we discussed the history of biocontainment as an outgrowth of medical research, especially the effort to develop vaccines for various worldwide diseases. We provided some definition of the biosafety levels (BSLs) established by the Centers for Disease Control and Prevention (CDC) based on risk considerations. We also discussed the regulatory regime for biological agents and, specifically, for designing a facility for an FDA or EU regulated product within the confines of the safety practices dictated by the CDC and design requirements of the NIH.

  • Bioprocess Facility Design — Layout Rules And Configurations

    Expansions and renovations to existing biological facilities, and construction of new facilities, provide a unique opportunity to rethink basic design strategies and use new technologies to build a better facility that will improve compliance. This article is the third in a six-part series on how single-use systems are changing the modern biotechnology facility and process design paradigm.

  • An Introduction To Biopharmaceutical Facility Design & Layout

    This article explores modern facility design principles that make use of the most flexible new technologies and provide a platform to rein in costs, reduce schedules, and deliver products compliantly and within business risk tolerance.

  • Single-Use Systems For Aseptic Fill/Finish

    Today’s disposable systems offer improved manufacturing efficiency, and better QA and regulatory compliance — and they can be the fastest route to media fills

  • Considering Options And Alternatives For The Design Of Complex Biopharma Facilities

    The movement of viral vectors, cell therapies and other antibody-based next-generation drug products toward commercialization is driving the need for new and different technologies and facilities. Engineering and design firms with the right skill sets can help you maintain the right balance in your facility design to maintain flexibility which is essential to meet diverse processing needs for biopharmaceutical manufacturing.